Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329095
Status:
COMPLETED
Last Update Posted:
2006-05-24
First Post:
2006-05-19
Brief Title:
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
Sponsor:
Robin Alan L MD
Organization:
Robin Alan L MD
Study Overview
Official Title:
An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures
Status:
COMPLETED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy qd or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either qd or bid in the same eyes Compliance will be measured over the two months of participation
Detailed Description:
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy qd or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either qd or bid in the same eyes Compliance will be measured over the two months of participation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None